Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, founded in 2006. With additional offices in Beijing, Suzhou, Hong Kong, and Singapore, the firm focuses on early to growth-stage investments across various sectors, including healthcare, information technology, consumer goods, mobile internet, artificial intelligence, and clean technology. Qiming Venture Partners has a strong track record, having invested in over 530 innovative companies, with more than 200 achieving successful exits through public offerings or mergers and acquisitions. The firm is recognized for its deep technical expertise and hands-on operational support, making it a preferred partner for CEOs and startups seeking to scale their operations. Its partners are often sought after as board members, reflecting their status as respected business leaders and thought leaders in the venture capital landscape.
Room3906 Jinmao Tower, 88 Century Boulevard, Shanghai 200121, China
Zhang Ao
Executive Director
Cyrus Chan
Associate
Nan Chen
Principal
David Chu
Partner
Anna French
Managing Partner
Yuxin Fu
Vice President
Jinda Gao
Principal
Kuantai Yeh
Partner
Robert Headley
Partner
Maykin Ho
Venture Partner
William Hu
Managing Partner
Duane Kuang
Founding Managing Partner
Nisa Leung
Managing Partner
Dingzheng Li
Vice President
Jing Liu
Vice President
Chang Liu
Associate
Bin Liu
Vice President
Biao Lu
Associate
Shuo Mao
Principal
Gary Rieschel
Founder and Managing Partner
Motao Sun
Vice President
Amy Tang
Venture Partner
Yi Tang
Principal
Shiyu Wang
Partner
Bonnie Wang
Principal
Rachel Wang
Venture Partner
James Wang
Venture Partner
Jing Wu
Partner
Gillian Xu
RMB funds CFO
Peter (Ming) Yin
Principal, Cleantech
Janet Yu
Partner
Yafeng Zhou
Associate
Alex Zhou
Partner
Zhiyuan Zhou
Associate
Jing-Shan Hu Ph.D
Venture Partner of Healthcare
Past deals in Manufacturing
DH-Robotics
Venture Round in 2025
DH-Robotics is a high-tech company that provides precision and motion control core components for industrial intelligent manufacturing scenarios. Their products include voice coil actuators, miniature electric table-type cylinders, electric grippers, and rotary electric grippers. They are confident that easy and adaptable intelligent identification and capture will provide robots with enhanced perception and execution capabilities.
DH-Robotics
Series C in 2024
DH-Robotics is a high-tech company that provides precision and motion control core components for industrial intelligent manufacturing scenarios. Their products include voice coil actuators, miniature electric table-type cylinders, electric grippers, and rotary electric grippers. They are confident that easy and adaptable intelligent identification and capture will provide robots with enhanced perception and execution capabilities.
PRCXI Biotechnology
Seed Round in 2024
PRCXI Biotechnology is a biotech company that provides bioinformatics and automation solutions for life science and the manufacturing of analytical instruments.
Lixin Huigan
Series A in 2023
Lixin Huigan is a full-service manufacturer of sensors and an application service provider with an emphasis on the creation of premium micro-nanosensors.
Jiangsu Jing Chuang Advanced Electronic Technology specializes in the research and development of semiconductor material cutting equipment.
Hochuen Medical
Series B in 2023
Hochuen Medical USA Corp. is a manufacturer of medical devices and consumables, specializing in In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices. Established in 2015 by Dr. Robin Liu and Eric Zeng, the company operates as an OEM/ODM manufacturer, providing services that range from product design and development to mass production. Hochuen Medical's product offerings include essential healthcare items such as COVID-19 testing kits, microfluidic biochips, and various medical disposables. The company is recognized for its commitment to quality, holding FDA registration and ISO certifications, and emphasizes research and development to offer innovative solutions for the healthcare sector. With a founding management team that possesses extensive experience in manufacturing and development, Hochuen Medical aims to address the evolving needs of medical professionals and patients through its diverse product portfolio.
Prismlab China
Series C in 2022
Prismlab China Ltd. is a high-tech enterprise established in 2005, specializing in the development, production, and sales of high-speed light-curing 3D printers. The company integrates optical, mechanical, electrical technology, and computer software and hardware, along with photopolymer materials, to produce advanced rapid prototyping machines based on SLA technology. With a global presence, its products are distributed across over 50 countries and regions, earning recognition and acclaim from users worldwide for their performance and innovation.
Cencorp Automation
Series A in 2022
Cencorp Automation is a provider of process automation solutions focused on the electronics industry. The company offers a diverse range of equipment solutions including depaneling, odd-form assembly, test handling, laser marking, laser welding, and final assembly. Their innovative automation platforms are designed to enhance productivity and quality for their customers, which include leading firms in car electronics, telecommunications, and industrial electronics. By delivering tailored solutions, Cencorp Automation significantly improves the efficiency of customers' production processes.
Zhenge Biotech
Series C in 2022
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Yesmro
Series C in 2022
Yesmro, also known as Yimai Gongpin, is a retail company focused on supplying automation parts and industrial supplies to small and medium-sized enterprises. The company offers an extensive range of products, including electrical accessories, wires and cables, and industrial control components, catering specifically to the needs of businesses involved in technological development. By leveraging technology and data-driven approaches, Yesmro aims to deliver affordable and convenient solutions, enabling small enterprises to easily access the industrial products they require for their operations. The company's commitment to providing long-tail services ensures that even niche market needs are met efficiently and cost-effectively.
Xinchuangyuan Semiconductor
Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.
Rox Motor
Series B in 2021
ROX Motor is a company dedicated to the development of off-road new energy vehicles, focusing on innovations in smart car technologies. The firm specializes in research and development in areas such as new energy power, intelligent cockpit systems, and autonomous driving. By providing advanced solutions in three-electric technology and intelligent driving, ROX Motor aims to enhance product quality within the new energy vehicle industry. The company's commitment to integrating cutting-edge technologies supports its mission to lead in the smart vehicle market.
Hochuen Medical
Series A in 2021
Hochuen Medical USA Corp. is a manufacturer of medical devices and consumables, specializing in In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices. Established in 2015 by Dr. Robin Liu and Eric Zeng, the company operates as an OEM/ODM manufacturer, providing services that range from product design and development to mass production. Hochuen Medical's product offerings include essential healthcare items such as COVID-19 testing kits, microfluidic biochips, and various medical disposables. The company is recognized for its commitment to quality, holding FDA registration and ISO certifications, and emphasizes research and development to offer innovative solutions for the healthcare sector. With a founding management team that possesses extensive experience in manufacturing and development, Hochuen Medical aims to address the evolving needs of medical professionals and patients through its diverse product portfolio.
Render
Series A in 2021
Render is a Chinese manufacturer of high-tech medical products and solutions. Render is a Shenzhen-based company that was founded in 2010.
Just Medical
Series B in 2021
Just Medical is a developer and manufacturer of orthopedic medical devices, specializing in artificial implants such as hip and knee joints, as well as internal fixation products and surgical instruments. The company emphasizes research and development in orthopedics, aiming to enhance surgical efficiency and improve the quality of orthopedic treatment. Just Medical is dedicated to providing safe and effective medical products and services, continually refining its product systems to alleviate patient pain and support healthcare professionals in their surgical procedures.
P&R Measurement Technology
Series C in 2021
P&R Measurement Technology Co., Ltd., founded in 2011 and headquartered in Zhuhai, China, specializes in the research, development, and supply of testing and automation solutions. The company caters to various industries, including motors, household appliances, consumer electronics, and energy power. With a strong emphasis on engineering signal processing and acoustic/vibration testing, P&R Measurement offers a range of custom and semi-custom engineering testing equipment, as well as data processing and finite element simulation analysis services. The company operates subsidiaries in Guangzhou, Suzhou, Hong Kong, and the United States, with additional offices in Qingdao, Hefei, Shunde, and Ningde, enhancing its capacity to serve a diverse clientele.
Rox Motor
Series A in 2021
ROX Motor is a company dedicated to the development of off-road new energy vehicles, focusing on innovations in smart car technologies. The firm specializes in research and development in areas such as new energy power, intelligent cockpit systems, and autonomous driving. By providing advanced solutions in three-electric technology and intelligent driving, ROX Motor aims to enhance product quality within the new energy vehicle industry. The company's commitment to integrating cutting-edge technologies supports its mission to lead in the smart vehicle market.
Zhenge Biotech
Series B in 2021
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Delta Medical
Series E in 2021
Demei Medical specializes in the design and manufacture of sports medicine surgical equipment, intraoperative consumables, and rehabilitation products, with a focus on arthroscopic surgery and sports rehabilitation products.
MoreWis
Series B in 2021
Morewis is a platform service provider focused on the digital transformation of the manufacturing industry. It develops the MC MorewisCloud industrial Internet platform, which facilitates a collaborative ecosystem for industrial software development and application. MorewisCloud offers customized solutions and industrial application software, including manufacturing operations management (MOM), manufacturing execution systems (MES), and warehouse management systems (WMS). The company's offerings are utilized across various sectors, such as surface mounted technology, electronic assembly, green energy battery solutions, and smart factories. By integrating data analytics and real-time monitoring into production processes, Morewis enables its clients to enhance efficiency and optimize operations.
Delta Medical
Series D in 2020
Demei Medical specializes in the design and manufacture of sports medicine surgical equipment, intraoperative consumables, and rehabilitation products, with a focus on arthroscopic surgery and sports rehabilitation products.
Club Factory
Series D in 2019
Club Factory built an integrated supply chain from manufacturers to consumers for cross-border e-commerce. They scan the whole Internet to find factories which sell on Wish/Ebay/Amazon, and bring consumers the best prices.
Delta Medical
Series C in 2019
Demei Medical specializes in the design and manufacture of sports medicine surgical equipment, intraoperative consumables, and rehabilitation products, with a focus on arthroscopic surgery and sports rehabilitation products.
Bomming Vision
Series A in 2019
Zhuhai Bomming Vision Technology is a high-tech company based in Zhuhai, China, specializing in machine vision technology. With a core team possessing over 15 years of experience in image acquisition, recognition, algorithms, and machine vision inspection, the company focuses on developing vision processing software systems and manufacturing high-precision optical inspection equipment. These products are designed for quality assurance across various industries, ensuring accuracy and reliability in optical measurements.
Emergen
Series B in 2019
Emergen, operated by Zhejiang Zhichang Group, focuses on the development and manufacturing of intelligent robots and comprehensive manufacturing solutions. The company has developed two core technologies: a distributed intelligent robot controller and an HCPS intelligent intellectual network. These innovations support high-performance robotic systems and industrial solutions that are integral to smart factory construction. Emergen’s products enable closed-loop control of process data, ensuring traceability of quality information and facilitating intelligent logistics management. By concentrating on creating robotic products with independent intellectual property rights, the company aims to reduce reliance on foreign brands in critical components of robotics, contributing to the advancement of intelligent manufacturing in China.
NASN Automotive Electronics
Series B in 2019
NASN Automotive Electronics Co., Ltd. is a manufacturer based in Shanghai, China, specializing in electronic chassis control products and autonomous driving technologies for the automotive market. The company offers a range of products, including the NBooster intelligent brake system, brushless electric steering EPS controller, and wire control systems. By focusing on research and development, production, and sales, NASN aims to provide advanced and comprehensive solutions that enhance vehicle safety and intelligence, catering to the growing demand for innovative automotive technologies in China.
P&R Measurement Technology
Series A in 2018
P&R Measurement Technology Co., Ltd., founded in 2011 and headquartered in Zhuhai, China, specializes in the research, development, and supply of testing and automation solutions. The company caters to various industries, including motors, household appliances, consumer electronics, and energy power. With a strong emphasis on engineering signal processing and acoustic/vibration testing, P&R Measurement offers a range of custom and semi-custom engineering testing equipment, as well as data processing and finite element simulation analysis services. The company operates subsidiaries in Guangzhou, Suzhou, Hong Kong, and the United States, with additional offices in Qingdao, Hefei, Shunde, and Ningde, enhancing its capacity to serve a diverse clientele.
Bomming Vision
Series A in 2018
Zhuhai Bomming Vision Technology is a high-tech company based in Zhuhai, China, specializing in machine vision technology. With a core team possessing over 15 years of experience in image acquisition, recognition, algorithms, and machine vision inspection, the company focuses on developing vision processing software systems and manufacturing high-precision optical inspection equipment. These products are designed for quality assurance across various industries, ensuring accuracy and reliability in optical measurements.
VR Medical
Series B in 2017
VR Medical, a US based company, was established in 2009 to provide medical device companies, and distributors, a new and more effective low-cost, high-quality manufacturing resource. They’re focused on serving the needs of medical device companies by providing a single-sourced solution for new product development, out sourcing, contract manufacturing, and secure product distribution within China.
Bomming Vision
Series A in 2017
Zhuhai Bomming Vision Technology is a high-tech company based in Zhuhai, China, specializing in machine vision technology. With a core team possessing over 15 years of experience in image acquisition, recognition, algorithms, and machine vision inspection, the company focuses on developing vision processing software systems and manufacturing high-precision optical inspection equipment. These products are designed for quality assurance across various industries, ensuring accuracy and reliability in optical measurements.
Cencorp Automation
Series A in 2016
Cencorp Automation is a provider of process automation solutions focused on the electronics industry. The company offers a diverse range of equipment solutions including depaneling, odd-form assembly, test handling, laser marking, laser welding, and final assembly. Their innovative automation platforms are designed to enhance productivity and quality for their customers, which include leading firms in car electronics, telecommunications, and industrial electronics. By delivering tailored solutions, Cencorp Automation significantly improves the efficiency of customers' production processes.
LP Amina
Series C in 2013
LP Amina focuses on products that improve coal-fired power plant's emissions and efficiency. Leveraging 50 unique patented products to improve the firing system of a coal-fired boiler, including Rotating Vane Wheels, High Performance Classifiers, Coal Pipe Balancing Technologies, and Burner Enhancements, the Company provides products and solutions that will meet or exceed the expectations of their customers. Furthermore, LP Amina's corporate culture is one of a relentless pursuit of continuous improvement. Utilizing the latest technology and traditional know-how from the World's two largest users of Coal for power generation, the Company is well positioned to develop new products and solutions to meet the ever changing needs of Power Industry. LP Amina's staff has over 20 years of experience in the design, fabrication, installation and commissioning of coal-fired power plants. During this time, the team has gained a wide range of experience from the evolution of the US Power Market. Increases in environmental regulations and free market driven energy prices have forced plant operators to reduce emissions and improve reliability while lowering operational cost. LP Amina's engineering and design team will leverage this experience gained from the US and Europe to address the emergence of similar issues in China.
Novast
Series D in 2011
Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.
Novast
Series C in 2011
Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.
BTR
Series A in 2010
BTR is a professional manufacturer specializing in the production of positive and negative electrode materials for lithium-ion secondary batteries. The company engages in the research, development, and sales of products related to these batteries, as well as the application of nanometer materials. BTR is owned by China Baoan Group and is committed to advancing technology in the field of energy storage through its innovative offerings.
Aeonmed Medical Treatment
Series A in 2010
Aeonmed Medical Treatment is a manufacturer and supplier specializing in operating theatre and intensive care unit (ICU) devices. The company focuses on developing a range of medical equipment, including anesthesia machines, operating beds, infusion pumps, mechanical ventilation systems, and nebulizers. Additionally, Aeonmed offers comprehensive medical treatment system solutions that encompass anesthesia and operation support, emergency and critical care, and medical engineering equipment. Their product offerings also include five major medical system solutions, such as laminar flow monitoring and centralized gas supply. Since its inception, Aeonmed has prioritized clinical demands and innovation, resulting in a robust portfolio of over 600 authorized patents, with more than 400 being invention patents, reflecting a commitment to advancing healthcare technology.
LP Amina
Series B in 2009
LP Amina focuses on products that improve coal-fired power plant's emissions and efficiency. Leveraging 50 unique patented products to improve the firing system of a coal-fired boiler, including Rotating Vane Wheels, High Performance Classifiers, Coal Pipe Balancing Technologies, and Burner Enhancements, the Company provides products and solutions that will meet or exceed the expectations of their customers. Furthermore, LP Amina's corporate culture is one of a relentless pursuit of continuous improvement. Utilizing the latest technology and traditional know-how from the World's two largest users of Coal for power generation, the Company is well positioned to develop new products and solutions to meet the ever changing needs of Power Industry. LP Amina's staff has over 20 years of experience in the design, fabrication, installation and commissioning of coal-fired power plants. During this time, the team has gained a wide range of experience from the evolution of the US Power Market. Increases in environmental regulations and free market driven energy prices have forced plant operators to reduce emissions and improve reliability while lowering operational cost. LP Amina's engineering and design team will leverage this experience gained from the US and Europe to address the emergence of similar issues in China.
Novast
Series B in 2009
Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.
Novast
Series B in 2008
Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.
LP Amina
Series A in 2008
LP Amina focuses on products that improve coal-fired power plant's emissions and efficiency. Leveraging 50 unique patented products to improve the firing system of a coal-fired boiler, including Rotating Vane Wheels, High Performance Classifiers, Coal Pipe Balancing Technologies, and Burner Enhancements, the Company provides products and solutions that will meet or exceed the expectations of their customers. Furthermore, LP Amina's corporate culture is one of a relentless pursuit of continuous improvement. Utilizing the latest technology and traditional know-how from the World's two largest users of Coal for power generation, the Company is well positioned to develop new products and solutions to meet the ever changing needs of Power Industry. LP Amina's staff has over 20 years of experience in the design, fabrication, installation and commissioning of coal-fired power plants. During this time, the team has gained a wide range of experience from the evolution of the US Power Market. Increases in environmental regulations and free market driven energy prices have forced plant operators to reduce emissions and improve reliability while lowering operational cost. LP Amina's engineering and design team will leverage this experience gained from the US and Europe to address the emergence of similar issues in China.
Fangtek
Series C in 2006
Shanghai Fangtek Electronics Co., Ltd. is an integrated circuit design company that specializes in the development and marketing of analog and mixed-signal power management integrated circuits. Founded in 2003 and based in Shanghai, with an additional office in Shenzhen, Fangtek's product offerings include audio power amplifiers, LED drivers, SIM card controllers, analog switches, reset integrated circuits, charger protection products, and voltage regulators. These products cater to various applications in communications, computing, and consumer electronics, including mobile phones, audio devices, and lighting systems. Fangtek is committed to delivering innovative and cost-effective solutions, leveraging its expertise in power device technologies and mixed-signal design to serve industries focused on voice, light, and electrical management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.